Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)

Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00742794

Acronym

ZU-HVA-001

Enrollment

200

Registered

2008-08-28

Start date

2008-08-31

Completion date

2010-08-31

Last updated

2010-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hymenoptera Sting Allergy

Brief summary

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Interventions

OTHERObservation

Observation of sting frequency

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria

* None

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026